Breast cancer: are long-term and intermittent endocrine therapies equally effective?

PURPOSE: In breast cancer (BC), the duration of endocrine adjuvant therapies (AT) has been extended continuously up to 10 years. We present an alternative explanation for the effect, which could enable shorter treatments. METHOD: The relevant literature on chemoprevention and (neo-)adjuvant therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Engel, Jutta, Schubert-Fritschle, Gabriele, Emeny, Rebecca, Hölzel, Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Review – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324413/
https://www.ncbi.nlm.nih.gov/pubmed/32472445
http://dx.doi.org/10.1007/s00432-020-03264-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324413/
https://www.ncbi.nlm.nih.gov/pubmed/32472445
http://dx.doi.org/10.1007/s00432-020-03264-0

Ejemplares similares